STAA News and Press, STAAR Surgical Company From 09/20/23

2023-09-20 11:26:22 ET Summary EYE experienced weak sales performance and a decline in gross margin in 2Q, raising concerns about its growth potential and profit margins. The termination of its partnership with WMT adds uncertainty to its long-term growth prospects and will impact...

2023-09-14 14:20:57 ET More on STAAR Surgical Seeking Alpha’s Quant Rating on STAAR Surgical Historical earnings data for STAAR Surgical Financial information for STAAR Surgical STAAR Surgical Company: The Stock Is Still An Eyesore STAAR Surgic...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, will host Vision 2026, the Company’s investor day, at the Nasdaq MarketSite in Times Square today. To honor the occasion and celebrate the 40th anniversary of be...

2023-09-08 14:28:55 ET More on STAAR Surgical Seeking Alpha’s Quant Rating on STAAR Surgical Historical earnings data for STAAR Surgical Financial information for STAAR Surgical STAAR Surgical Company: The Stock Is Still An Eyesore STAAR Surgic...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will host an in-person Investor Day on Thursday, September 14, 2023, beginning at 8:00 a.m. Eastern Time in New York City. The “Visio...

2023-08-18 06:07:52 ET More on Dolby Laboratories, Regency Centers, etc. STAAR Surgical Company: The Stock Is Still An Eyesore STAAR Surgical: Economic Realities Beginning To Surface, Reiterate Hold Regency Centers Corporation ( REG ) Q2 2023 Earnings Call Tran...

Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600 Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600 PR Newswire NEW YORK , Aug. 17, 2023 /PRNewswire/ -- Dolby Laboratori...

2023-08-11 06:22:38 ET Summary STAAR Surgical Company's revenue continues to grow, but its bottom line financial performance has been disappointing. The stock is trading at a very high price, making it overpriced compared to similar firms. More likely than not, the stock shoul...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced its partnership with Will Levis, quarterback for the Tennessee Titans of the National Football League (NFL). This partnership will raise awareness of the EVO ...

2023-08-09 02:36:04 ET Summary STAAR Surgical Company's Q2 FY'23 earnings missed consensus estimates. The key revenue driver for STAA is its Implantable Collamer Lenses, which saw a 21% YoY increase in unit volumes. Despite potential topline growth, the economic realities and ...